Systemic lipopolysaccharide compromises the blood-labyrinth barrier and increases entry of serum fluorescein into the perilymph.

Hirose, Keiko; Hartsock, Jared J; Johnson, Shane; Santi, Peter; Salt, Alec N

Hirose, Keiko; Hartsock, Jared J; Johnson, Shane; Santi, Peter; Salt, Alec N.

Affiliation

Hirose K; Department of Otolaryngology, Washington University School of Medicine, 660 South Euclid Avenue, Campus, Box 8115, St. Louis, MO, 63110, USA, keiko_hirose@post.harvard.edu.

J Assoc Res Otolaryngol ; 15(5): 707-19, 2014 Oct.

Article in En | MEDLINE | ID: mdl-24952083

Subject(s)

Blood-Brain Barrier/drug effects; Ear, Inner/metabolism; Fluorescein/metabolism; Lipopolysaccharides/pharmacology; Perilymph/metabolism; Animals; Cochlea/metabolism; Mice; Mice, Inbred C57BL; Permeability; Sodium/metabolism

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Perilymph / Blood-Brain Barrier / Lipopolysaccharides / Fluorescein / Ear, Inner Limits: Animals Language: En Journal: J Assoc Res Otolaryngol Journal subject: OTORRINOLARINGOLOGIA Year: 2014 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google